Trying to eat more trains your body to ignore important signals
Real-world evidence from UK and European databases suggests that patients with type 2 diabetes and fatty liver who receive GLP-1 therapy experience improvements in liver enzyme levels (ALT, AST) and non-invasive markers of fibrosis
When released after eating, GLP-1 signals the pancreas to produce insulin, reduces the release of glucagon, slows stomach emptying, and communicates with the brain to increase feelings of fullness
A Metabolic Win with Reproductive Perks As interest in these medications grows, many men have concerns about how GLP-1 therapy might impact their fertility, hormone levels, and sexual health
If Youve Never Tried Wegovy: CVS Caremark requires that you attempt Wegovy first
Muscle, metabolism & nerve support supplement